Outset Medical, Inc.

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.  The Tablo Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and  operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone.  The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and  a proprietary data analytics platform powering a new holistic approach to dialysis care.  

SLR Capital Partners

Baxter Ventures

Warburg Pincus

T. Rowe Price

Partner Fund Management

Perceptive Advisors

Fidelity Management and Research Company

D1 Capital Partners

Fidelity

Every time #TeamOutsetMedical gets together, we find ways to connect with each other, our communities and the causes we care about. At our National Sales Meeting last week, the team took time to give back to a cause close to so many of our hearts — empowering and supporting U.S. military servicemembers and their families.

As part of #operationlegacy with the Travis Manion Foundation, we assembled 1,000 care packages for donation to the Fort Campbell USO. The care packages were filled with gratitude, love, and essential items, our way of making a meaningful impact on the lives of those serving our nation and their loved ones. #BetterBeginsNow

#IfNotMeThenWho #TeamBuilding #MilitarySupport #VeteransSupport #CommunityService #ThankYouVeterans

NYU Langone Health Hospital — Long Island's #TabloDialysis program is empowering both patients and staff alike with remote monitoring, an innovative care model, and greater patient autonomy. Introducing Tablo "was a game changer," says FAITH LYNCH, DNP, RN, CNN, director of acute and home dialysis services. 

Read more about how NYU Langone Hospital is leading the way in dialysis care innovation: 

Switching to home hemodialysis can be game-changing. David Rush, a recording artist and patient advocate, gained back precious time. Terry, in rural Illinois, now enjoys treatments around his lifestyle, not tedious commutes. Regina, always active and vibrant, found empowerment being proactive and accountable in her care.

See how #Tablodialysis has made a profound impact on each of their lives. 

#BetterBeginsNow


Our Chair & CEO Leslie Trigg and CFO Nabeel Ahmed spoke this week at the 42nd Annual J.P. Morgan Healthcare Conference, where they highlighted the difference we strive to make in the lives of patients -- our moral mission -- as well as our growth as a company over the past year. We shared our progress serving acute care providers, with #TabloDialysis systems now in use at more than 650 facilities, including the top 8 national health systems and top 10 subacute providers, bolstered by a 34% increase in the number of Tablo consoles placed across home and acute care settings in 2023. #BetterBeginsNow #JPMHC24

It's like Coach Ted Lasso said, sometimes you've just gotta "believe."

#BetterBeginsNow #TeamTablo #TabloDialysis #NewYearVibes

NASDAQ:OM

Outset Medical, Inc.

Last Close

3.71

26/07 20:00

Market Cap

205.86M

Beta: 1.48

Volume Today

347.66K

Avg: 593.47K

PE Ratio

−0.89

PFCF: −1.08

locale

market

industry

website

ipo date

peer of

Earnings

Earnings per Share (Estimate*)

Revenue (Estimate*)

Metrics